GSK has application to expand use of mepolizumab accepted by EMA
(Alliance News) - GSK PLC on Monday said it has had an application to expand the use of mepolizumab for the treatment of chronic obstructive pulmonary disease accepted for review by the European ...
Healthline9d
Nucala (Mepolizumab) Cost and Financial Assistance
The price you pay for Nucala may depend on factors such as your health or medical insurance and the pharmacy used. Financial assistance may be available to help you with the cost of Nucala.
Pharmaceutical Technology on MSN9d
EMA to review GSK’s Nucala for COPD treatment expansion
The European Medicines Agency (EMA) has agreed to review GSK’s application of expanding Nucala’s (mepolizumab) use as add-on ...